Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Cancer Lett. 2018 Nov 14;442:333–340. doi: 10.1016/j.canlet.2018.11.007

Table 2.

HHLA2 IHC labeling analysis of peritumoral and adenocarcinoma tissues.

PDAC cohort
Peritumoral tissues (n=91) HHLA2 positivity rate
  Normal and inflammed duct cells   9/91(9.89%)
  Acinar cells   1/91(1.09%)
  Islet cells   3/91(3.29%)
  PanIN (n=20)   19/20(95%)
Adenocarcinoma (n=92)   71/92(77.17%)